Wird geladen...
Understanding the molecular basis of acute myeloid leukemias: where are we now?
Although the treatment modalities for acute myeloid leukemia (AML) have not changed much over the past 40 years, distinct progress has been made in deciphering the basic biology underlying the pathogenesis of this group of hematological disorders. Studies show that AML development is a multicause, m...
Gespeichert in:
| Veröffentlicht in: | Int J Hematol Oncol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Future Medicine Ltd
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172002/ https://ncbi.nlm.nih.gov/pubmed/30302223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh-2017-0002 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|